THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
Home › Medical Disclaimer

Medical & Educational Disclaimer

All content is provided strictly for educational and professional pharmacy reference and does not replace patient-specific medical advice.

Open Interactive Platform & Full Workspace →

Statutory Medical, Pharmaceutical & Educational Disclaimer

All content published on THE INDIAN PHARMACIST (https://theindianpharmacist.com)—including the 744 Medicine, Oncology, Restricted-Drug & Non-Drug Reference Profiles, 20 Sports Performance & Exercise Pharmacology Monographs, 32 Clinical & Dispensing Calculators, 40 Knowledge Hub Articles, 63 Academic Curriculum Chapters, and 17 Indian Pharmacy Law Summaries—is provided strictly for academic instruction, competitive examination preparation (GPAT, NIPER, Drug Inspector, RRB/CGHS Pharmacist), and professional reference.

1. Not a Substitute for Professional Clinical Judgment or Prescribing Label

Nothing on this website constitutes patient-specific medical advice, clinical diagnosis, treatment endorsement, or retail medication solicitation. Healthcare professionals must exercise independent clinical judgment and verify all drug dosages, contraindications, reconstitution diluents, infusion rates, and renal/hepatic adjustments against the manufacturer's current package insert approved by the Central Drugs Standard Control Organization (CDSCO), the Indian Pharmacopoeia (IP) & National Formulary of India (NFI), and institutional hospital protocols before administering or dispensing any medicine.

2. Strict Prohibition Against Self-Medication & Schedule H / H1 / X / NDPS Notice

Members of the public must never self-medicate, initiate, alter, or discontinue any prescription medicine based on educational monographs on this website. Under the Drugs and Cosmetics Act, 1940 and Rules, 1945 and the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, medicines classified under Schedule H, Schedule H1, Schedule X, and NDPS may only be dispensed by a Registered Pharmacist against a valid prescription issued by a Registered Medical Practitioner (RMP). High-alert medications, cytotoxic oncology agents (Oncology Monographs), and restricted drugs (Restricted Monographs) carry severe, potentially life-threatening toxicity risks and require specialist supervision.

3. Jurisdiction & Brand Example Clarification

Where Indian commercial brand examples are cited across monographs, they are included solely for educational generic-to-brand recognition during prescription auditing and ward rounds; inclusion does not imply commercial endorsement or therapeutic superiority over bioequivalent generic preparations listed in the National List of Essential Medicines (NLEM 2022) or Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). Read our Editorial Policy and Terms of Use for full governance standards.

Statutory, Regulatory & Compendial Reference Matrix for Indian Pharmacy Practice

Every institutional policy, examination resource, and clinical reference module on THE INDIAN PHARMACIST adheres to the primary statutory frameworks governing pharmaceutical education, drug regulation, pharmacovigilance, and essential medicine access in India:

Statutory / Compendial Authority Governing Legislation / Standard Core Scope in Pharmacy Practice & Education Platform Reference Module
Central Drugs Standard Control Organization (CDSCO) Drugs and Cosmetics Act, 1940 & Rules, 1945; New Drugs and Clinical Trials (NDCT) Rules, 2019 New drug approval, import registration, Schedule C/C1, G, H, H1, X, and Revised Schedule M (GMP) enforcement across India. Indian Pharmacy Law Hub (17 Statutes)
Indian Pharmacopoeia Commission (IPC), Ghaziabad Indian Pharmacopoeia (IP 2022), National Formulary of India (NFI), & PvPI Official compendial identity, purity, assay, dissolution, sterility standards, and national adverse drug reaction (ADR) reporting. 744 Verified Medicine & Reference Profiles
Ministry of Health & Family Welfare (MoHFW) National List of Essential Medicines (NLEM 2022) & National Health Programmes Selection of 384 essential medicines across 27 therapeutic categories stratified by Primary (P), Secondary (S), and Tertiary (T) care levels. 679-Drug Side-by-Side Comparison Centre
Pharmacy Council of India (PCI) Pharmacy Act, 1948; Education Regulations (ER-2020); Pharmacy Practice Regulations, 2015 Registration of pharmacists, D.Pharm/B.Pharm/Pharm.D curriculum standards, Good Pharmacy Practice (GPP), and patient counselling ethics. 63 Academic Curriculum Chapters & 80 Flashcards